First Light Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-14,054
| Closed | -$797K | – | 68 |
|
|
2016
Q1 | $797K | Buy |
14,054
+164
| +1% | +$9.3K | 0.4% | 41 |
|
|
2015
Q4 | $3.27M | Sell |
13,890
-452
| -3% | -$106K | 1.37% | 29 |
|
|
2015
Q3 | $2.27M | Buy |
14,342
+1,986
| +16% | +$314K | 1.12% | 32 |
|
|
2015
Q2 | $4.67M | Buy |
12,356
+1,080
| +10% | +$409K | 2.2% | 18 |
|
|
2015
Q1 | $4.71M | Buy |
11,276
+1,035
| +10% | +$433K | 2.41% | 14 |
|
|
2014
Q4 | $2.8M | Buy |
10,241
+720
| +8% | +$197K | 1.59% | 23 |
|
|
2014
Q3 | $1.85M | Buy |
9,521
+231
| +2% | +$44.9K | 1.27% | 26 |
|
|
2014
Q2 | $2.27M | Buy |
9,290
+453
| +5% | +$111K | 1.53% | 25 |
|
|
2014
Q1 | $2.34M | Buy |
8,837
+1,097
| +14% | +$291K | 1.66% | 25 |
|
|
2013
Q4 | $2.81M | Buy |
+7,740
| New | +$2.81M | 2.38% | 16 |
|